secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pharma-Bio Serv, Inc. (PBSV)
CIK:        0001304161
Form:       8-K
Filed at:   2023-02-09T23:59:59+00:00
Accession:  0001654954-23-001509
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pharma-Bio Serv adopts amended bylaws adding advance notice, supermajority vote requirement
--------------------------------------------------------------------------------

- Advance notice bylaw established as exclusive means for stockholder proposals and nominations.
- Stockholder action by written consent requires delivery within 60 days and proper method per DGCL.
- Board now solely sets board size; vacancies filled by remaining directors.
- Stockholder amendments to bylaws require 66 2/3% supermajority vote.
- Indemnification provisions added for directors, officers, employees, and agents.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1304161/000165495423001509/0001654954-23-001509-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1304161/000165495423001509/pbsv_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-001509

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer